FDA Inspection
Mercury Clinical Research IncMercury Clinical Research Inc – FDA Inspection, Jun 18, 2020
Record Details
This FDA Inspection record concerns Mercury Clinical Research Inc, with an inspection on June 18, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- June 18, 2020
- Product Type
- Drugs
View Company Profile
ID · 4a433b9b-49b9-4ad5-ae6f-637914e881e6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1124066
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.50Ensuring compliance with plan and protocol
- 21 CFR 312.57(a)Records of receipt, shipment, disposition
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.